Daniel Lysák
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 41
- Chronic Myeloid Leukemia Treatments 16
- Hematopoietic Stem Cell Transplantation 15
- Acute Myeloid Leukemia Research 10
- Genetics 34
- Chronic Lymphocytic Leukemia Research 24
- Mesenchymal stem cell research 9
- Co-authors
- Pavel Jindra (29 shared papers)Grzegorz Mazur (1 shared paper)Agnieszka Wierzbowska (1 shared paper)Xavier Thomas (1 shared paper)Anna Dmoszyńska (1 shared paper)Jyh-Pyng Gau (1 shared paper)Christopher Arthur (1 shared paper)Mark D. Minden (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)Hematological Oncology (3 papers)Annals of Hematology (3 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- CzechiaUnited StatesUnited Kingdom
In The Last Decade
Daniel Lysák
73 papers receiving 1.9k citations
Daniel Lysák's Hit Papers
Peers
Comparison fields: 5 of 91
- Hematology 1.1k
- Genetics 671
- Transplantation 76
- Pathology and Forensic Medicine 347
- Immunology 332
Countries citing papers authored by Daniel Lysák
This map shows the geographic impact of Daniel Lysák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lysák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lysák more than expected).
Fields of papers citing papers by Daniel Lysák
This network shows the impact of papers produced by Daniel Lysák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lysák. The network helps show where Daniel Lysák may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Lysák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 818 |
| 2 | ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia Hit paper breakdown → | 2020 | 252 |
| 3 | 2022 | 65 | |
| 4 | 2010 | 49 | |
| 5 | 2005 | 46 | |
| 6 | 2019 | 43 | |
| 7 | 2021 | 34 | |
| 8 | 2014 | 31 | |
| 9 | 2015 | 28 | |
| 10 | 2016 | 28 | |
| 11 | 2019 | 26 | |
| 12 | 2011 | 25 | |
| 13 | 2010 | 22 | |
| 14 | 2013 | 22 | |
| 15 | Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia Hit paper breakdown → | 2025 | 21 |
| 16 | 2019 | 21 | |
| 17 | 2016 | 19 | |
| 18 | 2010 | 19 | |
| 19 | 2018 | 17 | |
| 20 | 2016 | 17 |
About Daniel Lysák
Daniel Lysák is a scholar working on Hematology, Genetics, Immunology, Pathology and Forensic Medicine and Oncology, having authored 83 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (18 papers), Chronic Myeloid Leukemia Treatments (16 papers), Hematopoietic Stem Cell Transplantation (15 papers), Immune Cell Function and Interaction (11 papers), Acute Myeloid Leukemia Research (10 papers), Mesenchymal stem cell research (9 papers) and Renal Transplantation Outcomes and Treatments (7 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (671 citations), Transplantation (76 citations), Pathology and Forensic Medicine (347 citations) and Immunology (332 citations). Daniel Lysák has collaborated with scholars based in Czechia, United States and United Kingdom. Frequent co-authors include Pavel Jindra, Grzegorz Mazur, Agnieszka Wierzbowska, Xavier Thomas, Anna Dmoszyńska, Jyh-Pyng Gau, Christopher Arthur, Mark D. Minden, Albert Oriol and Hagop M. Kantarjian. Their work appears in journals such as Journal of Clinical Oncology, Blood, Hematological Oncology, Annals of Hematology and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.